Investors
A Leader in Inhaled Pharmaceuticals

This section of the website provides information for existing and potential investors in Vectura Group plc including financial reports, an interactive share price chart and updates on our latest news.

Why invest in us?

Vectura's focused application of technology, know-how and expertise has demonstrated that the potential for new inhaled pharmaceuticals with real therapeutic and commercial value can be realised.

Latest performance

Share price chart

Reports and presentations

Vectura Group plc annual report for the year ended 31 March 2012

Vectura Group plc Preliminary Results for year ended 31st March 2012

JP Morgan HealthCare Conference

Webcast

Share price
Upcoming event
21 May 2013

Full Year Results